Positron Corp. · OTC:POSC

Positron — Investor Presentation (2025)

20 slides from Positron's investor presentation, 2025

  1. Slide 1: The Future of Cardiac Imaging

    Positr On) The Future of Cardiac Imaging

  2. Slide 2: At the foundation of cardiac PET imaging

    At the foundation of cardiac PET imaging Positron is a leading medical technology company that co-develops, manufactures, and sells advanced PET and PET-CT imaging systems, along with providing comprehensive clinical services to nuclear medicine healthcare providers across North America. Positron pr

  3. Slide 3: Sharper. Faster. Smaller. Smarter PET-CT Solutions.

    Sharper. Faster. Smaller. Smarter PET-CT Solutions. Positron's state-of-the- art PET-CT a Positron's Affinity PET-CT 4D 64-Slice scanner will command the market with its superior image quality, compact size, and affordability. Positron’s NeuSight PET-CT 64-Slice scanner is the perfect solution for e

  4. Slide 4: The evolution to PET-CT

    Premium Imaging. Unmatched Value. The evolution to PET-CT = Positron The industry trend is shifting towards comprehensive nuclear cardiac study environments, demanding the integration of a PET-CT system for in-depth diagnostics. Positron’s new state-of-the-art Affinity PET-CT 4D 64-Slice scanner and

  5. Slide 5: Exceptional nuclear imaging at the industry's best price

    Premium Imaging. Unmatched Value. Exceptional nuclear imaging at the industry's best price Positron lowers barriers to entry for nuclear cardiologists, radiologists, and healthcare practices by offering unparalleled nuclear imaging technology and clinical services at the most affordable prices. For

  6. Slide 6: Imaging innovation

    Imaging innovation Affinity PET-CT 4D 64-Slice Scanner Advanced design provides optimal operator controV/user experience Internally self-shielded quality control source Intelligent QC Optimum image fusion creates excellent clinical performance High specificity and sensitivity High resolution Core te

  7. Slide 7: Key factors driving growth in cardiac PET imaging

    State of the Industry Key factors driving growth in cardiac PET imaging Industry Trends: | Shift from SPECT to PET modality. Improved patient care requires cutting-edge technology for sustainability and value. Market Advancements: Introduction of new radiopharmaceuticals boosts market confidence. So

  8. Slide 8: Adoption and growth

    State of the Industry Adoption and growth With its dominance in the nuclear imaging device market, technological advancements, vast applications in cardiac and oncology, and strong demand from hospitals and practices, the PET-CT industry presents significant growth opportunities and revenue potentia

  9. Slide 9: Evolution to PET-CT

    State of the Industry Evolution to PET-CT Market Dynamics: Technological Advancements: | Growing universal demand for improved healthcare outcomes. PET-CT imaging infrastructure outpaces other modalities with stronger long-term viability. Disruption in traditional imaging through advanced technology

  10. Slide 10: Evolution to the PET modality

    State of the Industry Evolution to the PET modality Certain healthcare providers are transitioning from SPECT imaging to PET imaging, whereas others are opting to incorporate PET as a complementary modality. Industry Transformation: SPECT Challenges: Transition from SPECT to PET-CT is reshaping Domi

  11. Slide 11: Market demand

    State of the Industry Market demand Market Trends and Demands: PET is emerging as the premier modality for cardiac imaging, recommended as the primary diagnostic test. Shift towards PET driven by advancements in quantitative imaging, diagnostic software, and device technology, particularly PET-CT. E

  12. Slide 12: Positron is the best value

    Positron is the best value Positron offers systems and services at the most economical price in the industry with annual service agreements as the high margin income generator. Direct marketing efforts and directly sell to the existing 10,000 nuclear cardiology practices and hospitals base. Leverage

  13. Slide 13: Meet the Team

    Meet the Team Our Leadership Adel Abdullah President and Chairman Mr. Abdullah has a master’s degree in aerospace and mechanical engineering from the University of Arizona and brings 30 years’ experience with device companies in the nuclear imaging technologies field. Adel led Positron in the develo

  14. Slide 14: Support

    Support Positron Support Team and Partners Positron is supported by a highly qualified team consisting of: Sales, service, and installation technicians who are specialists in nuclear imaging systems and experts in Positron’s Attrius dedicated PET and the new NeuSight PET-CT 64-Slice scanner and Affi

  15. Slide 15: Recent Developments

    Recent Developments Positron milestones Positron has acquired ownership of the 510(k) for the NeuSight PET-CT from Neusoft Medical Systems which is a prerequisite for FDA market clearance for current and subsequent PET-CT systems. Affinity PET-CT Efficacy and Performance Research Positron and Ochsne

  16. Slide 16: Total Addressable Market

    Total Addressable Market PET-CT device market is the future of molecular imaging With its substantial market value, projected growth, and a sizeable customer base spanning private practices and hospitals, the PET-CT device market presents a promising opportunity for companies to capitalize on the in

  17. Slide 17: The burden of cardiovascular disease and cancer in America

    Data Points Scope Stats (Mortality Rates) The burden of cardiovascular disease and cancer in America Cardiovascular disease and cancer pose significant health and economic challenges for the nation, highlighting the critical need for advanced diagnostic and treatment solutions. Cardiology Cardiovasc

  18. Slide 18: Why Positron?

    Market Factors Why Positron? With its cutting-edge technology, industry partnerships, and competitive advantages, Positron's Affinity PET-CT 4D 64-Slice scanners and NeuSight's PET-CT 64-Slice scanners are poised to revolutionize nuclear imaging and provide superior solutions for cardiac and oncolog

  19. Slide 19: Catalyst

    Catalyst Positron and the PET modality are the future of molecular imaging PET-CT Reimbursement Soars Now the preferred cardiac diagnostic Oncology's Dominance PET-CT demand surges, seeking innovation SPECT to PET-CT Shift Driven by doubling reimbursements and medical advancements Global Expansion N

  20. Slide 20: The Future of Cardiac Imaging

    Positr On) The Future of Cardiac Imaging www.positron.com

Positron — Investor Presentation (2025) on 6ix